UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000030242
Receipt number R000034324
Scientific Title Phase II study of nivolumab + bevacizumab + paclitaxel in patients with HER2-negative metastatic breast cancer Nivolumab Evaluation With BEvacizumab And pacliTaxel (NEWBEAT) study (WJOG9917B)
Date of disclosure of the study information 2017/12/04
Last modified on 2023/08/08 14:05:56

No. Disposal Last modified on Item of update
1 Insert 2017/12/04 09:36:42
2 Update 2018/06/04 09:07:40 Recruitment status
Anticipated trial start date
3 Update 2018/10/29 11:23:03 Recruitment status
4 Update 2019/06/06 09:34:29 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2019/06/06 09:39:36 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/06/06 09:40:34 Date of IRB
7 Update 2020/12/05 12:13:39 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2021/12/06 09:44:37 Date of closure to data entry
Date trial data considered complete
9 Update 2022/12/07 09:11:01 Recruitment status
10 Update 2023/08/03 11:17:14 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
11 Update 2023/08/08 14:05:56 Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email
Address